Cargando…

HTA54 Incorporating Value of Health System Impact in Economic Evaluations of Therapies of Chronic Diseases

Detalles Bibliográficos
Autores principales:	Marczell, K, Szabó, G, Benedict, Á
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747488/ http://dx.doi.org/10.1016/j.jval.2022.09.1514

Ejemplares similares

Living HTA: Automating Health Economic Evaluation with R
por: Smith, Robert A., et al.
Publicado: (2022)

Health technology assessment (HTA) and economic evaluation: efficiency or fairness first
por: Richardson, Jeff, et al.
Publicado: (2018)

Evaluating facts and facting evaluations: On the fact‐value relationship in HTA
por: Hofmann, Bjørn, et al.
Publicado: (2018)

HTA253 Payer Perspectives on the Impact of the COVID-19 Pandemic on Health Technology Assessments (HTA) in Europe
por: Hutcheson, R, et al.
Publicado: (2022)

The Impact of Brexit on Pharmaceuticals and HTA
por: Lorgelly, Paula K
Publicado: (2018)

The Experience of Patients in Chronic Care Management: Applications in Health Technology Assessment (HTA) and Value for Public Health
por: Pennestrì, Federico, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on HTA
Publicado: (2020)

HTA and National Immunisation Program: an overview of competent bodies and of the impact of HTA on the decision-making process
por: Ricciardi, W
Publicado: (2022)

The impact of HTA reports on health policy: a systematic review
por: Gerhardus, Ansgar, et al.
Publicado: (2005)

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA)
por: Brettschneider, Christian, et al.
Publicado: (2011)

Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings
por: Marsh, Kevin, et al.
Publicado: (2018)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

HTA65 Socio-Economic Determinants of Health Status During COVID-19 Pandemic in Hungary
por: Xu, FF, et al.
Publicado: (2022)

Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
por: Chavarina, Kinanti Khansa, et al.
Publicado: (2023)

HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19
por: Warttig, S, et al.
Publicado: (2022)

Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline
por: Chavarina, Kinanti Khansa, et al.
Publicado: (2023)

GMS-HTA: Information out of the world of HTA - up-to-date, comprehensive and valid
por: Rüther, Alric
Publicado: (2005)

Ethical analysis in HTA of complex health interventions
por: Lysdahl, Kristin Bakke, et al.
Publicado: (2016)

Landscape analysis of health technology assessment (HTA): systems and practices in Asia
por: Teerawattananon, Yot, et al.
Publicado: (2019)

HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations
por: Hoxhaj, Ilda, et al.
Publicado: (2022)

Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
por: Makady, Amr, et al.
Publicado: (2017)

Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
por: Lach, Krzysztof, et al.
Publicado: (2017)

Hospital-based health technology assessment (HTA) in Finland: a case study on collaboration between hospitals and the national HTA unit
por: Halmesmäki, Esa, et al.
Publicado: (2016)

HB-HTA as an implementation problem in Polish health policy
por: Gałązka-Sobotka, Małgorzata, et al.
Publicado: (2021)

PIN62 Recognising the broader value of vaccines in HTA: ready for prime time?
por: Brassel, S., et al.
Publicado: (2021)

POSC254 The Impact of COVID-19 on European HTA Decisions
por: Watson, C, et al.
Publicado: (2022)

International HTA Experience with Targeted Therapy Approvals for Lung Cancer
por: Maraiki, Fatma, et al.
Publicado: (2018)

Use of Surrogate end points in HTA
por: Mangiapane, Sandra, et al.
Publicado: (2009)

Ethics in HTA: Examining the "Need for Expansion"
por: Abrishami, Payam, et al.
Publicado: (2017)

Health technology assessment (HTA) increasingly important in spine research
por: van Tulder, Maurits
Publicado: (2011)

The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment
por: Grimm, Sabine Elisabeth, et al.
Publicado: (2017)

HTA and Gastric Cancer: Evaluating Alternatives in Third- and Fourth-Line Patients
por: Ferrario, Lucrezia, et al.
Publicado: (2023)

HTA and economics in the United States: a systematic review of ICER reports to evaluate trends, identify factors associated with recommendations, and understand implications
por: Kruzikas, Denise T, et al.
Publicado: (2020)

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice
por: Tafuri, Giovanni, et al.
Publicado: (2016)

Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective
por: Kisser, Agnes, et al.
Publicado: (2021)

Impact of 2008 global economic crisis on suicide: time trend study in 54 countries
por: Chang, Shu-Sen, et al.
Publicado: (2013)

Why and how can HTA support evidence-informed health policymaking?
por: Gutiérrez-Ibarluzea, I, et al.
Publicado: (2022)

ICER’s Version of HTA Is Positioned to Guide U.S. Health Care Reform
por: Watkins, John B.
Publicado: (2020)

HTA assessment of COVID-19 interventions in Ireland
Publicado: (2020)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer
por: Bretoni, Alberto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_66uuseqip32lhkmrbccnvi1nst